Latest News
Upcoming Events
H.C. Wainwright Biotech On Tap 2026
Lausanne XIII 13th Annual Workshop
Chardan’s 10th Annual Healthcare Conference
Past Events
Roth Healthcare Opportunities Conference
ProMIS Neurosciences and Nasdaq mark World Alzheimer’s Day at the Nasdaq Tower
Latest Financial Results
Q2 2026
Quarter Ended Jun 30, 2026
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2025
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
ProMIS™ Neurosciences, Inc. (Nasdaq: PMN), is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). The Company has offices in Toronto, Ontario, and Cambridge, Massachusetts.
Cambridge, MA
Address
Cambridge Innovation Center
1 Broadway
Cambridge, MA 02142
U.S.A.
Toronto, Canada
Address
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
Canada